EFLUELDA

This brand name is authorized in Austria, Croatia, Ireland, Israel, Poland, Romania, Spain.

Active ingredients

The drug EFLUELDA contains a combination of these active pharmaceutical ingredients (APIs):

1	A/Victoria/4897/2022 (H1N1)pdm09-like strain (A/Victoria/4897/2022, IVR-238)
	Read more about Influenza, inactivated, split virus
2	A/Darwin/9/2021 (H3N2)-like strain (A/Darwin/9/2021, SAN-010)
	Read more about Influenza, inactivated, split virus
3	B/Austria/1359417/2021-like strain (B/Michigan/01/2021, wild type)
	Read more about Influenza, inactivated, split virus
4	B/Phuket/3073/2013-like strain (B/Phuket/3073/2013, wild type)
	Read more about Influenza, inactivated, split virus

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BB02	Influenza, purified antigen	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	85068
HR	Agencija za lijekove i medicinske proizvode	HR-H-238554415
IL	מִשְׂרַד הַבְּרִיאוּת	9135
PL	Rejestru Produktów Leczniczych	100421170
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66869001, W66869002, W66869003, W66869004, W66869005, W66869006